Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation

Yaoxue Xuebao

Volumn 46, Issue 3, 2011, Pages 305-310

  Li, Jia Ming ^a   Zhao, Yong Hai ^a   Zhong, Guo Chen ^a   Long, Zi Jiang ^a   Zhou, Peng ^a   Yuan, Ming ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Ferulic acid; Ferulic acid derivatives; Platelet aggregation inhibition; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; FERULIC ACID DERIVATIVE; OZAGREL; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG EFFECT; DRUG SYNTHESIS; IN VIVO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; COUMARIC ACIDS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; RANDOM ALLOCATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79953227396     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yu DQ. Prospect in the study of creating new drugs from Chinese herbal medicine [J]. Acta Acad Med Sin, 2002, 24: 335-338.
2. Ma FS, Li JM, Li CR, et al. The research progresses of ferulic acid derivatives and its bioactivities [J]. Prog Pharm Sci, 2008, 32: 345-350.
3. Li JM, Zhao YH, Ma FS, et al. Synthesis of ligustrazine-aromatic acid derivatives and their inhibitory effect on platelet aggregation [J]. Chin J Org Chem, 2008, 28: 1578-1583.
4. Iizuka K, Akahance K, Momose D, et al. Highly selective inhibitors of thromboxane synthetase. 1. Imidazole derivatives [J]. J Med Chem, 1981, 24: 1139-1148. (Pubitemid 12208769)
5. Liu XJ, Fang L, Cheng MS. Progress of TXSIs and TXA2 receptor antagonists [J]. Prog Pharm Sci, 2002, 26: 143-146.
6. Takamuro I, Sekine Y, Tsuboi Y, et al. A pyrazolopyrimidine compound and a process for preparing the same: WO2004064721A2[P]. 2004-08-05.
7. Kato K, Ohkawa S, Terao S, et al. Thromboxane synthetase inhibitors (TXSI). Design, synthesis, and evaluation of a novel series of omega-pyridylalkenoic acids [J]. J Med Chem, 1985, 28: 287-294.
8. Chemical Computing Group Inc. MOE 2008.10, Copyright (c) 1997-2008.
9. Gao Y, Voigt J, Zhao H, et al. Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif [J]. J Med Chem, 2001, 44: 2869-2878. (Pubitemid 32879116)
10. Das U, Alcom J, Shrivastav A, et al. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy) phenylcarbonyl]-3, 5-bis (arylidene)-4-piperidones and related compounds [J]. Eur J Med Chem, 2007, 42: 71-80. (Pubitemid 46198985)
11. Lee K, Lee JH, Boovanahalli KS, et al. (Aryloxyacetylamino) benzoic acid analogues: a new class of hypoxia-inducible factor-1 inhibitors [J]. J Med Chem, 2007, 50: 1675-1684. (Pubitemid 46564388)
12. Lv PC, Li HQ, Xue JY, et al. Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents [J]. Eur J Med Chem, 2009, 44: 908-914.
13. Zhang AL, Xu QP, Sun JL, et al. Experiment study of the effects of compound gingko Guttate Pills against thrombosis and platelet aggregation [J]. J Beijing Univ Tradit Chin Med 2004, 27: 42-44.